Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
iTeos Therapeutics, Inc. (ITOS) had Receiveable Turnover of 1.94 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$12.60M |
|
$-112.64M |
|
-- |
|
$12.60M |
|
$163.70M |
|
$-151.10M |
|
$42.07M |
|
$-109.03M |
|
$-109.03M |
|
$-112.64M |
|
$-112.64M |
|
$-112.64M |
|
$-112.64M |
|
$-151.10M |
|
$-160.44M |
|
35.76M |
|
35.76M |
|
$-3.15 |
|
$-3.15 |
|
| Balance Sheet Financials | |
$550.65M |
|
$4.70M |
|
$116.94M |
|
$667.59M |
|
$40.01M |
|
-- |
|
$52.35M |
|
$92.36M |
|
$575.23M |
|
$575.23M |
|
$575.23M |
|
35.84M |
|
| Cash Flow Statement Financials | |
$-103.76M |
|
$72.66M |
|
$1.11M |
|
$285.04M |
|
$251.45M |
|
$-33.59M |
|
$27.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1199.69% |
|
-1199.69% |
|
-1273.82% |
|
-865.66% |
|
-894.34% |
|
$-106.72M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
|
Receiveable Turnover |
1.94 |
188.37 |
|
-19.58% |
|
-19.58% |
|
-16.87% |
|
-19.58% |
|
$16.05 |
|
$-2.98 |
|
$-2.90 |
|